DCB Angioplasty for Coronary Lesions: an OCT Analysis

CompletedOBSERVATIONAL
Enrollment

70

Participants

Timeline

Start Date

December 1, 2020

Primary Completion Date

July 1, 2021

Study Completion Date

July 20, 2021

Conditions
Coronary StenosisDrug-coated Balloon
Interventions
PROCEDURE

Percutaneous coronary intervention

All patients were treated with a loading dose of clopidogrel 300 or 600 mg before the procedure followed by maintenance clopidogrel 75 mg daily for 6 months. 100 U/ kg of unfractionated heparin was injected intravenously to maintain an activated clotting time ≥ 250 s during the procedure. For DCB treatment, the patient underwent predilation with an optimal-sized balloon (non-compliant balloon or cutting balloon) based on angiography (balloon-to-vessel ratio of 1.0), with the standard balloon shorter than the intended DCB size. The DCB was sized at 1:1 balloon-to-vessel ratio, delivered rapidly (median of 15 s) and inflated at nominal pressure for 60 s.

Trial Locations (1)

116011

The First Affiliated Hospital of Dalian Medical University, Dalian

All Listed Sponsors
lead

The First Affiliated Hospital of Dalian Medical University

OTHER

NCT04984135 - DCB Angioplasty for Coronary Lesions: an OCT Analysis | Biotech Hunter | Biotech Hunter